Charles Schwab Investment Management Inc Kura Oncology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 635,494 shares of KURA stock, worth $5.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
635,494
Previous 624,952
1.69%
Holding current value
$5.26 Million
Previous $12.2 Million
54.67%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding KURA
# of Institutions
192Shares Held
77.5MCall Options Held
103KPut Options Held
106K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.8MShares$48 Million0.71% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...